** Shares of medical device maker Kestra Medical Technologies KMTS.O set to open 95% above offer price in Nasdaq debut

** Stock indicated to open at $33.15 vs $17 IPO price

** KMTS, backed by buyout firm Bain Capital, sold ~11.9 mln shares in its upsized offering - 19% more than initially offered, and above its marketed range of $14 and $16 apiece to raise $202 mln

** Listing marks first notable March IPO and the third medical device maker flotation in New York since October

** KMTS competes in the wearable cardioverter defibrillator market that has been dominated by Zoll Medical

** BofA Securities, Goldman Sachs and Piper Sandler were the lead bookrunners for the offering

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com;))